Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore

Antimicrobial Resistance and Infection Control

Volumn 4, Issue 1, 2015, Pages

  Ling, Moi Lin ^a   Tee, Yong Ming ^a   Tan, Soong Geck ^a   Amin, Ismawati M ^a   How, Kue Bien ^a   Tan, Kwee Yuen ^a   Lee, Lai Chee ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Carbapenem resistant; Enterobacteriaceae; Epidemiology; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEMASE; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGAPORE; TERTIARY HEALTH CARE;

EID: 84938485191     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/s13756-015-0066-3     Document Type: Article

References (23)

1. Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007;51:763-5.
2. Rhee JY, Park YK, Shin JY, et al. KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother. 2010;54:2278-9. doi: 10.1128/AAC.00011-10 . Epub 2010 Mar 8.
3. Chia JH, Su LH, Lee MH, et al. Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure. Microb Drug Resist. 2010;16:317-25. doi: 10.1089/mdr.2009.0048 . Epub 2010 Jun 6.
4. Balm MN, Ngan G, Jureen R, Lin RT, Teo J. Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore. J Clin Microbiol. 2012;50:475-6. doi: 10.1128/JCM.05914-11 . Epub 2011 Nov 23.
5. Yong D, Toleman MA, Giske CG, et al. Characterisation of a new metallo- β -lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046-54.
6. Chien JM, Koh TH, Chan KS, et al. Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient. Scand J Infect Dis. 2012;44:312-4. doi: 10.3109/00365548.2011.633549 . Epub 2011 Nov 29.
7. Ng E, Earnest A, Lye DC, et al. The excess financial burden of multidrug resistance in severe gram-negative infections in Singaporean hospitals. Ann Acad Med Singapore. 2012;41:189-93.
8. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol. 2010;31:620-6.
9. Munoz-Price LS, Cuesta CDL, Adams S, et al. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol. 2010;31:1074-7.
10. Lerner A, Abu-Hanna K, Meitus I, et al. Environmental contamination by carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2013;51:177-81.
11. Kotsanas D, Wijesooriay WR, Korman TM, et al. "Down the drain": carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust. 2013;198:267-9.
12. Kritsotakis EI, Tsioutis C, Roumbelaki M, et al. Antibiotic use and the risk of carbapenem-resistant extended spectrum-β-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother. 2011;66:1383-91.
13. Schechner V, Kotlovsky T, Tarabeia J, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol. 2011;32:497-503.
14. Patel N, Harrington S, Dihmess A, et al. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother. 2011;66:1600-8.
15. Liu S, Chang H, Chia J, et al. Outcomes and characteristics of ertapenem non-susceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study. J Microbiol Immunol Infect. 2012;45:113-9.
16. Lee GC, Lawson KA, Burgess DS. Clinical epidemiology of carbapenem-resistant Enterobacteriaceae in community hospitals: a case-case-control study. Ann Pharmacother. 2013;47:1115-21. doi: 10.1177/1060028013503120 .
17. Bhargava A, Hayakawa K, Silverman E, et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol. 2014;35:398-405. doi: 10.1086/675614 .
18. Borer A, Saidel-Odes L, Eskira S, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am J Infect Control. 2012;40:421-5.
19. Falagas ME, Rafailidis PI, Kofteridis D, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother. 2007;60:1124-30.
20. Rosenthal VD, Maki DG, Salomao R, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145:582-91.
21. Moreno CA, Rosenthal VD, Olarte N, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol. 2006;27:349-56.
22. Whitley E, Ball J. Statistics Review 4. Sample size calculations. Crit Care. 2002;6:335-41.
23. Chitnis AS, Caruthers PS, Rao AK, et al. Outbreak of carbapenem-resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol. 2012;33:984-92.